PanScan is a multi-stage genome-wide association study (GWAS) of pancreatic cancer conducted within the framework of the NCI Cohort Consortium. Investigators have conducted two GWAS, PanScan I and PanScan II, that have led to the discovery of four novel regions in the genome associated with risk for pancreatic cancer. Additional epidemiologic and genetic studies using data from these initial studies are now underway. The third phase of the project, PanScan III, will analyze more than 3,000 pancreatic cancer cases from 14 cohorts, including those from PanScan I and II, to discover novel regions of the genome associated with pancreatic cancer susceptibility.
For more information, contact Rachael Stolzenberg-Solomon.